Ethynyldeoxyuridine (EdU) suppresses in vitro population expansion and in vivo tumor progression of human glioblastoma cells

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Neuro-Oncology

• Publication date

  2011-06-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11060-011-0621-6PMID 21643840PMCID PMC3202677
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Isolation and expansion of the adult mouse neural stem cells using the neurosphere assay.

  2010cited by this paper
• Different molecular patterns in glioblastoma multiforme subtypes upon recurrence

  2009cited by this paper
• Cell type specific applicability of 5‐ethynyl‐2′‐deoxyuridine (EdU) for dynamic proliferation assessment in flow cytometry

  2009cited by this paper
• Isolation, expansion, and differentiation of adult Mammalian neural stem and progenitor cells using the neurosphere assay.

  2009cited by this paper
• Bromodeoxyuridine inhibits cancer cell proliferation in vitro and in vivo.

  2008cited by this paper
• Production of neurospheres from CNS tissue.

  2008cited by this paper
• Glioblastoma in adults.

  2008cited by this paper
• Antiviral Activities and Phosphorylation of 5-halo-2'-Deoxyuridines and N-Methanocarbathymidine in Cells Infected with Vaccinia Virus

  2008cited by this paper
• Bromodeoxyuridine Induces Senescence in Neural Stem and Progenitor Cells

  2008cited by this paper
• A chemical method for fast and sensitive detection of DNA synthesis in vivo

  2008cited by this paper
• Long-term survival with glioblastoma multiforme.

  2007cited by this paper
• Management of glioblastoma

  2007cited by this paper
• 5-Alkynyl-2'-deoxyuridines: chromatography-free synthesis and cytotoxicity evaluation against human breast cancer cells.

  2007cited by this paper
• Cancer: Stem cells and brain tumours

  2006cited by this paper
• Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells

  2006cited by this paper
• Neural stem cell isolation and characterization.

  2006cited by this paper
• Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

  2005cited by this paper
• Generation and differentiation of neurospheres from murine embryonic day 14 central nervous system tissue.

  2005cited by this paper
• Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme.

  2005cited by this paper
• The application of 5-bromodeoxyuridine in the management of CNS tumors

  2005cited by this paper
• Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404.

  2004cited by this paper
• The first examples of a meta-benzannulation from the reaction of Fischer carbene complexes with alkynes.

  2003cited by this paper
• Azide–Alkyne Coupling: A Powerful Reaction for Bioconjugate Chemistry

  2003cited by this paper
• A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes.

  2002cited by this paper
• A Bone‐Seeking Clone Exhibits Different Biological Properties from the MDA‐MB‐231 Parental Human Breast Cancer Cells and a Brain‐Seeking Clone In Vivo and In Vitro

  2001influential reference
• Induction of senescence-associated genes by 5-bromodeoxyuridine in HeLa cells.

  2001cited by this paper
• The Amyloid Precursor Protein-binding Protein APP-BP1 Drives the Cell Cycle through the S-M Checkpoint and Causes Apoptosis in Neurons*

  2000cited by this paper
• A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme.

  1999cited by this paper
• 5-Bromodeoxyuridine induces senescence-like phenomena in mammalian cells regardless of cell type or species.

  1999cited by this paper
• A phase I trial of intravenous bromodeoxyuridine and radiation therapy for pancreatic cancer.

  1997cited by this paper
• A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases.

  1997cited by this paper
• Evaluation of bromodeoxyuridine in glioblastoma multiforme: a Northern California Cancer Center Phase II study.

  1991cited by this paper
• Measurement of the kinetics of DNA repair synthesis after uv irradiation using immunochemical staining of incorporated 5-bromo-2'-deoxyuridine and flow cytometry.

  1988cited by this paper
• A Phase I study of intermittent intravenous bromodeoxyuridine (BUdR) with conventional fractionated irradiation.

  1984cited by this paper
• Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication.

  1982cited by this paper
• The synthesis and properties of some 5-substituted uracil derivatives.

  1980cited by this paper
• EFFECT OF HALOGENATED PYRIMIDINES AND THYMIDINE ON GROWTH OF L-CELLS AND A SUBLINE LACKING THYMIDINE KINASE.

  1964cited by this paper
• MOLECULAR RADIOBIOLOGY OF HUMAN CELL LINES. V. COMPARATIVE RADIOSENSITIZING PROPERTIES OF 5-HALODEOXYCYTIDINES AND 5-HALODEOXYURIDINES.

  1963cited by this paper
• Effect of 5-bromodeoxyuridine incorporation on survival of cultured mammalian cells.

  1962cited by this paper
• Effect of 5-bromodeoxyuridine on mamalian chromosomes.

  1961cited by this paper
• GENETICS OF HUMAN CELL LINES

  1960cited by this paper
• Mode of action of 5-bromodeoxyuridine on mammalian cells in culture.

  1959cited by this paper

• Repurposing the DNA Labeling Agent EdU for Therapy Against Heterogeneous Patient Glioblastoma.

  2025cites this paper
• Genetic tracing and topography of spontaneous and stimulated cardiac regeneration in mice

  2025cites this paper
• Combinatorial treatment of glioblastoma with temozolomide (TMZ) plus 5-ethynyl-2′-deoxyuridine (EdU)

  2025cites this paper
• Combinatorial Treatment of Glioblastoma with Temozolomide (TMZ) Plus 5-Ethynyl-2’-deoxyuridine (EdU)

  2025cites this paper
• CldU sensitizes BRCA2 reverse-mutated cells to PARP inhibitors

  2025cites this paper
• Multi-oncogene targeting in cancer therapy: A miRNA-driven pharmacological approach.

  2025cites this paper
• New biochemical approaches for the treatment of glioblastoma

  2025influential citation
• Unveiling EdU detection: Surfactant-free synthesis of Pb nanocomposites for spectroscopic probing in human serum

  2025cites this paper
• Using Mosaic Cell Labeling to Visualize Polyploid Cells in the Drosophila Brain.

  2023cites this paper
• Dynamics of Endothelial Cell Generation and Turnover in Arteries During Homeostasis and Diseases

  2023cites this paper
• Basic Methods of Cell Cycle Analysis

  2023cites this paper
• Laboratory Techniques in Cellular and Molecular Medicine

  2022cites this paper
• Nucleotide excision repair removes thymidine analog 5-ethynyl-2′-deoxyuridine from the mammalian genome

  2022cites this paper
• Developmental Patterning and Neurogenetic Gradients of Nurr1 Positive Neurons in the Rat Claustrum and Lateral Cortex

  2021cites this paper
• Heterogeneities in Cell Cycle Checkpoint Activation Following Doxorubicin Treatment Reveal Targetable Vulnerabilities in TP53 Mutated Ultra High-Risk Neuroblastoma Cell Lines

  2021cites this paper
• A Protocol for Genome-Wide Analysis of DNA Replication Timing in Intact Root Tips.

  2021cites this paper
• 5-Ethynyl-2′-deoxycytidine and 5-ethynyl-2′-deoxyuridine are differentially incorporated in cells infected with HSV-1, HCMV, and KSHV viruses

  2020cites this paper
• Investigation of pyrimidine nucleoside analogues as chemical probes to assess compound effects on the proliferation of Trypanosoma cruzi intracellular parasites

  2020cites this paper
• Covalent labeling of nucleic acids.

  2020cites this paper
• Evaluating the Genotoxic and Cytotoxic Effects of Thymidine Analogs, 5-Ethynyl-2′-Deoxyuridine and 5-Bromo-2′-Deoxyurdine to Mammalian Cells

  2020cites this paper
• Design of reverse transcriptase–specific nucleosides to visualize early steps of HIV-1 replication by click labeling

  2019cites this paper
• Clicking a Fish: Click Chemistry of Different Biomolecules in Danio rerio.

  2018cites this paper
• Bioorthogonal Metabolic DNA Labelling using Vinyl Thioether-Modified Thymidine and o-Quinolinone Quinone Methide.

  2018cites this paper
• A Suzuki-Miyaura method for labelling proliferating cells containing incorporated BrdU.

  2018cites this paper
• Growth Suppression of Human Colorectal Cancer Cells with Mutated KRAS by 3-Deaza-cytarabine in 3D Floating Culture

  2018cites this paper
• DNA Replication: From Radioisotopes to Click Chemistry

  2018cites this paper
• Intraspinal transplantation of subventricular zone‐derived neural progenitor cells improves phrenic motor output after high cervical spinal cord injury

  2017cites this paper
• Arabidopsis RETINOBLASTOMA RELATED directly regulates DNA damage responses through functions beyond cell cycle control

  2017cites this paper
• Cellular responses to topoisomerase ll-mediated DNA lesions

  2017cites this paper
• Chains of magnetosomes with controlled endotoxin release and partial tumor occupation induce full destruction of intracranial U87-Luc glioma in mice under the application of an alternating magnetic field.

  2017cites this paper
• Quantification of cell cycle kinetics by EdU (5-ethynyl-2′-deoxyuridine)-coupled-fluorescence-intensity analysis

  2017cites this paper
• Looking for ugly ducklings: The role of the stability of BrdU-antibody complex and the improved method of the detection of DNA replication

  2017cites this paper
• Development of non-pyrogenic magnetosome minerals coated with poly-l-lysine leading to full disappearance of intracranial U87-Luc glioblastoma in 100% of treated mice using magnetic hyperthermia.

  2017cites this paper
• Isolating dividing neural and brain tumour cells for gene expression profiling.

  2016cites this paper
• Cycloadditions in Bioorthogonal Chemistry

  2016cites this paper
• Dr Jekyll and Mr Hyde: a strange case of 5-ethynyl-2′-deoxyuridine and 5-ethynyl-2′-deoxycytidine

  2016cites this paper
• Transcriptional profiling of dividing tumor cells detects intratumor heterogeneity linked to cell proliferation in a brain tumor model

  2016cites this paper
• Neurotoxic effects of AZT on developing and adult neurogenesis

  2015cites this paper
• Different neural crest populations exhibit diverse proliferative behaviors

  2015cites this paper
• A Fatal Combination: A Thymidylate Synthase Inhibitor with DNA Damaging Activity

  2015influential citation
• Phosphorylated 5-ethynyl-2'-deoxyuridine for advanced DNA labeling.

  2015cites this paper
• The Fingerprint of Anti-Bromodeoxyuridine Antibodies and Its Use for the Assessment of Their Affinity to 5-Bromo-2'-Deoxyuridine in Cellular DNA under Various Conditions

  2015cites this paper
• Cycloadditions for Studying Nucleic Acids

  2015cites this paper
• Different rates of DNA replication at early versus late S‐phase sections: Multiscale modeling of stochastic events related to DNA content/EdU (5‐ethynyl‐2′deoxyuridine) incorporation distributions

  2014cites this paper
• DNA damage signaling, impairment of cell cycle progression, and apoptosis triggered by 5‐ethynyl‐2′‐deoxyuridine incorporated into DNA

  2013cites this paper
• EdU induces DNA damage response and cell death in mESC in culture

  2013influential citation
• Adult neurogenesis in Drosophila.

  2013cites this paper
• Neuronal UV-Initiated Apoptosis is Prevented By 5-Bromo-2’-Deoxyuridine (BrdU) Or A Deficiency in Cockayne Syndrome B Or Xeroderma Pigmentosum A

  2012cites this paper
• Multicolor flow cytometry analysis of the proliferations of T‐lymphocyte subsets in vitro by EdU incorporation

  2012cites this paper
• Neural stem cells exposed to BrdU lose their global DNA methylation and undergo astrocytic differentiation

  2012cites this paper
• Dynamic metabolic labeling of DNA in vivo with arabinosyl nucleosides

  2011cites this paper